HOME > BUSINESS > HEALTHCARE

Glenmark to launch Desonide topical ointment in US

Glenmark Pharmaceuticals Inc said it has got the go-ahead to launch the generic version of Perrigo's anti-inflammation ointment Desonide Ointment in the US.Desonide Ointment, 0.05% had annual sales of approximately $23.4 million for the 12 month period ending July 2017, according to IMS Health sales data.Glenmark’s current portfolio consists

Read More

Biocon passes US-FDA inspection at Vishakapatanam plant

Biocon said the plant inspection conducted by the US Food and Drug Administration at its Vishakapatanam plant passed without incident."US FDA inspected our Active Pharmaceutical Ingredients (API) manufacturing facility in Wishakhapatnam, Andhra Pradesh from September 11 to 15, 2017 and completed the audit without any observations," it said.No form

Read More

Zydus Cadila to launch immuno-suppressant in the US

Pharma giant Zydus Cadila said it received final approval from the USFDA to market immunonsuppressant Mycophenolate Mofetil injection.The drug is indicated for use in combination with other drugs i.e., cyclosporine and corticosteroids for the prophylaxis of organ rejection in patients receiving renal, hepatic or cardiac transplants.The drug

Read More

Solar Power is a life saver in Chhattisgarh – Survey

The solar energy revolution may be all about saving the environment, but for the Indian state of Chhattisgarh, it's impact is more immediate, and life-saving.According to a first-of-its-kind study conducted on primary health centers in the state, PHCs with solar backup admitted 50% more patients and conducted almost twice

Read More

Dr Reddy’s hit by class action suit on “misleading statements” on FDA action

Pharma giant Dr Reddy's Labs today said that a class action lawsuit has been filed against it on behalf of shareholders, alleging that the company misled investors causing them to lose money on their investments."The lawsuit alleges that the company made materially false and/or misleading statements or omissions in

Read More

Glenmark Pharma gets USFDA approval for generic version of Mylan’s anti-inflammation ointment

Glenmark Pharmaceuticals said it has got the US FDA approval to sell the generic version of corticosteroid ointment Kenalog from Mylan Pharmaceuticals.The primary ingredient is triamcinolone, a corticosteroid that reduces the actions of chemicals in the body that cause inflammation.Kenalog Ointment has annual sales of approximately $26.3 million in the

Read More

Aurobindo Pharma HIV drug gets USFDA approval under PEPFAR

Aurobindo Pharma said it received tentative approval for its for anti-HIV drug Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate under the U.S. President's Emergency Plan for AIDS Relief or PEPFAR.The approved product is used for the treatment of HIV-1 infection along as a complete regimen in adults and pediatric patients weighing

Read More

10.6% of Indians have mental disorders; country faces severe shortage

About 10.6% of adults in India suffer from some sort of mental disorder, including substance abuse problems, a study by the National Institute of Mental Health and Neurosciences or NIMHANS found.The study was conducted in 12 states of India by the Bangalore-based institution.Those with mental disorders were classified as those

Read More

Strides Shasun to launch allergy drug in the US

Pharma company Strides Shasun said it had received approval allergy drug Cetirizine Hydrochloride in the US."The US market for Cetirizine Hydrochloride Capsules (Softgel) is approximately USD 60 mln, with only one other generic player," the company said."The product is ready for launch immediately and as in the case of OTC

Read More

Glenmark gets US FDA approval for generic version of Daiichi Sankyo’s hypertension drug

Glenmark Pharmaceuticals said it got approval from US authorities to launch a generic version of Daiichi Sankyo's hypertension drug Azor in various dosages.The drug had annual sales of approximately $211.6 million as of May.The approval was obtained from United States Food & Drug Administration for Amlodipine and Olmesartan Medoxomil tablets

Read More

Lupin launches eye drug in the US

Pharma company Lupin said it launched Moxifloxacin Hydrochloride eye solution in the US.Lupin's Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base), is an AT1 rated generic equivalent of Novartis Pharms Corp.'s Vigamox Ophthalmic solution.It is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the organisms.Vigamox

Read More